Uncategorized
May 18, 2021
WE-REACH Invests in Three Biomedical Innovations for Treatment Of Skin, Sepsis, & Kidney
Seattle, WA (May 18, 2021)—The Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) is pleased to announce investments in three new awards to expedite early-stage product development for promising biomedical innovations. The three awards are intended to reduce skin injury from wound dressing, to treat COVID-19 induced viral sepsis, and to treat kidney disease. We…
March 30, 2021
RADx-UP Research Opportunity
A Notice of Intent to Publish has just been released for another RADx-UP ROA on Return to School: https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-097.html To solicit research on COVID-19 diagnostic testing approaches to safely return children and staff to the in-person school setting in underserved and vulnerable communities.
NHLBI & ACC Innovation Showcase
The NHLBI Innovation Office is partnering with the American College of Cardiology (ACC) to put on an innovation showcase on April 1, 2021 from 4:00 – 7:00 pm PDT (7:00 – 10:00 pm EDT). It will feature a panel of NHLBI experts, a presentation of NHLBI innovation services, and presentations/Q&A with 6 NHLBI SBIR Phase II…
March 11, 2021
Women’s Entrepreneurship Symposium 3/17
Next Wednesday: Resources for protecting your intellectual property Don’t miss the next free, online installment of the 2021 annual Women’s Entrepreneurship Symposium (WES), “Resources for protecting your intellectual property,” coming Wednesday, March 17, from noon to 1:30 p.m. ET. Take this opportunity to learn about programs, resources, and information that can help with the protection…
January 5, 2021
Three Biomedical Innovations Spanning Neonatal to Elderly Care Win WE-REACH Go-To-Market Awards
Seattle, WA (January 5, 2021)—The Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) is pleased to announce three new awards to expedite early-stage product development for promising biomedical innovations. WE-REACH invests up to $200,000 for each project with added resources and support. Project funding is made possible by public-private partnerships including the NIH, University of…
December 18, 2020
Funding Opportunity: ITHS/Primate Center Pilot Ignition Award (Letter of Intent Due December 18, 2020)
Funding Opportunity Notification ITHS/Primate Center Pilot Ignition Award Deadline: January 18, 2021 Letter of Intent DUE: December 18, 2020 The Washington National Primate Research Center (WaNPRC) and the Institute of Translational Health Sciences (ITHS) are pleased to sponsor the Ignition Award, which focuses on the use of non-human primate models of human disease. The…
December 10, 2020
WE-REACH Executive Director Dr. Rodney JY Ho Named to National Academy of Inventors
The Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) is honored to announce that WE-REACH Executive Director and UWSOP Professor of Pharmaceutics Rodney JY Ho has been elected to the rank of NAI Fellow by the 2020 National Academy of Inventors Fellows Selection Committee and Board of Directors. “Dr. Ho has demonstrated a highly prolific…
November 23, 2020
Dr. Ho Talks Pfizer Vaccine Distribution with KOMO News 4
Dr. Rodney Ho, Executive Director of WE-REACH, discussed the Pfizer COVID-19 vaccine and the challenges of distributing a treatment that requires -80 degree Celsius freezer storage with KOMO News last Friday. While “it is logistically challenging,” Dr. Ho believes that “we have prepared the best as we can.” For the full story, follow the link…
November 13, 2020
WE-REACH Funds Two COVID-19 Rapid Diagnostics Projects as Part of Expanded Initiatives
Seattle, WA (November 13, 2020)—The Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) is pleased to announce two awards to develop rapid point-of-care diagnostic tests for COVID-19. By securing about $500k in additional funding from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), WE-REACH is investing in the development of rapid, portable COVID-19 testing…
August 24, 2020
NEW Fast track funding for developing COVID-19 biosensors for skin or oral cavities | Preapplications DUE September 9, 2020
WE-REACH is announcing fast track funding for early-stage projects aimed at developing biosensors for COVID-19 open to researchers in the Pacific Northwest. This one-time opportunity through the NIH is part of the Emergency RADx-Rad initiative to detect the virus or other biomarkers in nasal and oral cavities or skin. This funding is intended to support…
Previous page Next page